JTCS Concomitant Website
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Artyom Sedrakyan
John A. Elefteriades
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sedrakyan, A.
Right arrow Articles by Krumholz, H. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sedrakyan, A.
Right arrow Articles by Krumholz, H. M.
Related Collections
Right arrow Valve disease

J Thorac Cardiovasc Surg 2004;128:266-272
© 2004 The American Association for Thoracic Surgery


Surgery for acquired cardiovascular disease

Quality of life after aortic valve replacement with tissue and mechanical implants

Artyom Sedrakyan, MDa, Patricia Hebert, PhDb, Viola Vaccarino, MD, PhDc, A. David Paltiel, PhDa, John A. Elefteriades, MDd, Jennifer Mattera, MPHe, Zhenqiu Lin, PhDe, Sarah A. Roumanis, RNe, Harlan M. Krumholz, MDa,b,e,*

a Division of Health Policy and Administration, Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, Conn, USA
b Section of Cardiovascular Medicine, Department of Medicine, Yale University School of Medicine, New Haven, Conn, USA
c Department of Medicine, Division of Cardiology, Emory University School of Medicine, and Rollins School of Public Health, Atlanta, Ga, USA
d Section of Cardiothoracic Surgery, Yale University School of Medicine, New Haven, Conn, USA
e Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, Conn, USA

This study was presented at the 3rd Scientific Forum on Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke, Oct 1, 2001, Washington, DC.

Received for publication September 25, 2003; revisions received December 10, 2003; accepted for publication December 15, 2003.

* Address for reprints: Harlan M. Krumholz, MD, Yale University School of Medicine, 333 Cedar St, PO Box 208088, New Haven, CT 06520-8088, USA
harlan.krumholz{at}yale.edu

OBJECTIVES: We sought to determine whether changes in quality of life at 18 months following aortic valve replacement differ depending on the use of tissue valves or mechanical valves.

METHODS: We prospectively studied 73 patients with tissue valve replacements and 53 patients with mechanical valve replacements performed from April 1998 through March 1999 at Yale-New Haven Hospital. Quality of life was measured at baseline and at 18 months using the Medical Outcomes Trust Short Form 36-Item Health Survey.

RESULTS: Baseline unadjusted mean quality-of-life scores were lower in tissue valve recipients than in mechanical valve recipients and, for both groups, were generally lower than US population norms. At 18 months postoperatively, quality-of-life scores were greatly improved in both groups and were comparable to population norms (ie, within one-half a standard deviation). After adjusting for baseline quality of life, age, and other prognostic factors in an analysis of covariance, improvements in quality-of-life scores for tissue valve recipients versus mechanical valve recipients were similar. Of 10 (8 domains and 2 summary) scales examined, the only significant difference between the 2 groups was for the improvement in role limitations due to physical problems (Role Physical), which was more favorable in patients with mechanical valve implants (P = .04).

CONCLUSIONS: The use of tissue valve implants versus mechanical valve implants has little influence on improvement in quality of life at 18 months following aortic valve replacement. Thus, decisions about whether to choose a tissue valve or mechanical valve implant should depend upon other factors such as rates of complications and differences in the life span of the implants.





This article has been cited by other articles:


Home page
CirculationHome page
H. M. Krumholz
Outcomes Research: Generating Evidence for Best Practice and Policies
Circulation, July 15, 2008; 118(3): 309 - 318.
[Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
Y. S. Tjang, Y. van Hees, R. Korfer, D. E. Grobbee, and G. J.M.G. van der Heijden
Predictors of mortality after aortic valve replacement
Eur. J. Cardiothorac. Surg., September 1, 2007; 32(3): 469 - 474.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
L. Hellgren and E. Stahle
Quality of Life After Heart Valve Surgery With Prolonged Intensive Care
Ann. Thorac. Surg., November 1, 2005; 80(5): 1693 - 1698.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2004 by The American Association for Thoracic Surgery.